Status | Study |
Recruiting |
Study Name: Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer Condition: Fallopian Tube Cancer Ovarian Cancer Date: 2016-10-27 Interventions: Biological: Autologous Monocytes + ACTIMMUNE + SYLATRON The autologous monocytes cell product in 250ml t |
Not yet recruiting |
Study Name: p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer Condition: Ovarian Epithelial Cancer Fallopian Tube Cancer Date: 2015-04-28 Interventions: Drug: p53 gene p53 gene will b |
Terminated |
Study Name: Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer Condition: Ovarian Cancer Primary Peritoneal Cancer Date: 2014-10-23 Interventions: Drug: regorafenib Patients will be treated with Regorafenib 160 mg (4 x 40 mg tablets) daily for 21 days |
Terminated |
Study Name: A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers Condition: Recurrent Ovarian Cancer Fallopian Tube Cancer Date: 2012-07-10 Interventions: Drug: Cisplatin Cisplatin (75 |
Completed |
Study Name: TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer Condition: Fallopian Tube Cancer Ovarian Cancer Date: 2010-08-26 Interventions: Drug: AMG 386 Weekly Intraveno |
Completed |
Study Name: Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer Condition: Ovarian Cancer Fallopian Tube Cancer Date: 2009-12-10 Interventions: Drug: RAD001 RAD001 10mg is ta |
Terminated |
Study Name: Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer Condition: Ovarian Cancer Primary Peritoneal Serous Cancer Date: 2009-03-19 Interventions: Drug: bevacizumab Other Name: Avastin |
Suspended |
Study Name: A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Condition: Fallopian Tube Cancer Ovarian Cancer Date: 2008-09-12 Interventions: Drug: D4064A |
Completed |
Study Name: Hu3S193 in Treating Women With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Condition: Fallopian Tube Cancer Ovarian Cancer Date: 2008-02-15 Interventions: Biological: hu3S193 20 mg/m2, intravenous, weekly for a maximum of 3 cycles (of 8 weeks each) |
Active, not recruiting |
Study Name: Role of Spirituality in Coping and Surviving With Ovarian Cancer, Primary Peritoneal or Fallopian Tube Cancer Condition: Ovarian Cancer Peritoneal Cancer Fal Date: 2007-07-10 Interventions: Behavioral: Questionnaire Questionnaires that ask questions about religion, spirituality, and decisions |